Not the end of an inspiring journey at the Führungsakademie der DOG!
Over the past months, I had the privilege to learn, grow, and exchange ideas with an incredible group of p. This program has strengthened my skills and given me the chance to build many new friendship.
It was an honor to moderate and take part in this inspiring symposium at the DOG concerning the newest data and implications of real world studies.
Conferences are always a reminder of the importance of collaboration, innovation, and knowledge exchange in moving our field forward
On the way back from the annual meeting of the DOG 2025.
It was an honor to share the newest data of one of the largest real world studies with such an inspiring community of colleagues and experts in ophthalmology.
#DOG#ophthalmology#research#faricimab
How common is common?
New insights into Macular Curvature and Dome-Shaped Configuration based on data from the unique UK Biobank. This may open new fields to future #myopia and #macula research! @RetinaDiscoveryiovs.arvojournals.org/articl…
Now published:
Estimating excess visual loss from neovascular age-related macular degeneration in the UK during the COVID-19 pandemic: a retrospective clinical audit and simulation model bmjopen.bmj.com/content/12/4…
Well done @AlasdairWarwick, Darren Thomas. @RetinaDiscovery
The basis of #AI is reliability of the human gold standard. Check this out for features associated with #AMD. A further step into solving the riddle of retinal diseases. #fightingblindnessmedrxiv.org/content/10.1101/…
A great pleasure to present Paper #1 to predict function based on structure and demographics using #MachineLearning#AI . This might be a further step into future diagnostics.
nature.com/articles/s41598-0…
Honoured to have participated in this study investigating the application of #AI in retinal diseases. Worth reading!
Quantification of key retinal features in early and late age-related macular degeneration using deep learning ajo.com/article/S0002-9394(2…@RetinaDiscovery
I am honoured to announce that our landmark paper on genetic, demographic, imaging and functional association of #lipofuscin accumulation is now available with a 50 days' free access to the article. Enjoy it! authors.elsevier.com/c/1cALH…
I am glad to announce that our novel review article for #OCTA application and limitation for #GA secondary #AMD is now available online at Ophthalmologica and worth reading. An emerging field for an innovative imaging device.
karger.com/Article/Abstract/…@KargerPublisher
Now in pre-print @medrxivpreprint: the first synthetic trial in ophthalmology! We compared bevacizumab q6w PRN to fixed-interval aflibercept q8w in patients with neovascular #AMD. medrxiv.org/content/10.1101/…